nvestment Level in HIV Prevention Programs Related to HIV Incidence in the United StatesJanuary 31, 2007Researchers at Johns Hopkins Bloomberg School of Public Health conducted a historical analysis to examine the relationship between the Centers for Disease Control and Prevention's (CDC) HIV prevention budget and HIV incidence in the U.S. from 1978 to 2006. The results are published in the January 2007 edition of the American Journal of Preventive Medicine. The researchers found that from the beginning of the epidemic until 1985 (when new infections peaked), incidence of HIV predicted investment levels. During this period, society responded to increasing levels of infection with more investment in prevention programs. Things changed in the mid 1980s when investment levels began to predict incidence. That is, as the nation continued to increase the funding of HIV prevention programs, HIV dropped substantially from 160,000 infections per year to about 40,000 infections per year. In the early 1990s, as the level of investment (adjusted for inflation) flattened out with little annual change, so too did the number of new infections per year. This suggested to the researchers that level investment yields level incidence. "Our analysis helps explain why the number of new HIV infections has remained at 40,000 per year for over 15 years," said David R. Holtgrave, PhD, chair of the Department of Health Behavior and Society at the Bloomberg School of Public Health and lead author of the study. "Investment levels have predicted HIV incidence since the mid-1980s. If we want to lower infections further in the U.S., these analyses suggest we should consider increasing our national investment. Yes, that may seem expensive, but HIV medical care easily tops $20,000 per patient per year. Therefore, funding of effective, scientifically sound HIV prevention services are likely to have a very favorable return on investment in terms of both lives and dollars saved." Holtgrave noted that the analysis was based on historical data and is not a prospective trial of prevention effectiveness. Therefore, it is subject to methodological limitations. Nevertheless, he said it provides substantial indications of a strong relationship between the amount of national investment in HIV prevention and levels of new infections per year in the country. The paper"HIV Incidence and CDC's HIV Prevention Budget An Exploratory Correlational Analysis" was co-authored by Jennifer Kates, MPA, of the Kaiser Family Foundation. Johns Hopkins University |
|||||||||||||||||||||
| Related Hiv Prevention Current Events and Hiv Prevention News Articles Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. Scientists learn why even treated genital herpes sores boost the risk of HIV infection New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Teens are heading in wrong direction: Likely to have sex, but not use contraception Between 2003 and 2007, the progress made in the 1990s and early 2000s in improving teen contraceptive use and reducing teen pregnancy and childbearing stalled, and may even have reversed among certain groups of teens. Herpes medication does not reduce risk of HIV transmission A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2. Gains in access to antiretroviral treatment come with some costs In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia. Adult circumcision reduces risk of HIV transmission without reducing sexual pleasure Two studies presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA) show that adult circumcision reduces the risk of contracting the human immunodeficiency virus (HIV) and the risk of coital injury¬¬--without reducing pleasure or causing sexual dysfunction. Study details strategy for boosting ranks of black HIV/AIDS researchers African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide. About 500,000 African Americans are now living with HIV/AIDS. Clinical trial finds microbicide promising as HIV prevention method for women A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women. Anti-HIV gel shows promise in large-scale study in women An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States. South African policy on adolescents' rights to access condoms is causing confusion In 2007, South Africa's new Children's Act came into effect, granting children 12 years and older a host of rights relating to reproductive health, including the right to access condoms. More Hiv Prevention Current Events and Hiv Prevention News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||